|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.51 INR | +1.72% |
|
-1.99% | -7.09% |
| Market Cap | 1.6B 16.97M 14.62M 13.47M 12.64M 23.74M 23.99M 159M 61.99M 786M 63.68M 62.33M 2.72B | P/E 2024 |
-135x | P/E 2025 | 45.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98B 20.93M 18.03M 16.61M 15.59M 29.27M 29.58M 196M 76.45M 969M 78.53M 76.87M 3.36B | EV / Sales 2024 |
3.8x | EV / Sales 2025 | 2.93x |
| Free-Float |
39.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.72% | ||
| 1 week | -1.99% | ||
| Current month | +20.94% | ||
| 1 month | +19.91% | ||
| 3 months | +36.70% | ||
| 6 months | -4.77% | ||
| Current year | -7.09% |
| 1 week | 68 |  | 75.3 |
| 1 month | 54.65 | | 77.05 |
| Current year | 44.1 | | 84.7 |
| 1 year | 44.1 | | 121.44 |
| 3 years | 44.1 | | 176.59 |
| 5 years | 44.1 | | 267 |
| 10 years | 9.6 | | 267 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 2015-12-31 | |
| Director of Finance/CFO | 65 | 2014-06-30 | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2020-02-11 | |
| Chairman | 39 | - | |
| Director/Board Member | 79 | 2022-08-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.72% | -1.99% | -38.79% | -43.05% | 26.17M | |
| -1.03% | -1.98% | +40.77% | +146.46% | 1,001B | |
| -1.69% | -2.30% | +52.90% | +41.96% | 566B | |
| -1.07% | -1.47% | +19.49% | +60.81% | 393B | |
| -0.02% | +2.29% | +24.04% | +16.53% | 326B | |
| +0.02% | +0.84% | +25.60% | +32.13% | 276B | |
| +0.11% | -1.17% | +24.80% | +14.25% | 277B | |
| +3.35% | +2.31% | -40.65% | -46.50% | 193B | |
| -0.22% | +2.74% | +19.63% | +51.80% | 188B | |
| -0.34% | +4.57% | +17.62% | +63.47% | 158B | |
| Average | +0.11% | +0.21% | +14.54% | +33.79% | 337.68B | |
| Weighted average by Cap. | -0.50% | -0.41% | +29.26% | +66.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.06B 11.23M 9.68M 8.91M 8.37M 15.71M 15.88M 105M 41.03M 520M 42.15M 41.25M 1.8B | 1.35B 14.27M 12.3M 11.32M 10.63M 19.96M 20.17M 134M 52.12M 661M 53.55M 52.41M 2.29B |
| Net income | -24.89M -263K -227K -209K -196K -368K -372K -2.47M -962K -12.19M -988K -967K -42.25M | 80.12M 847K 730K 672K 631K 1.19M 1.2M 7.95M 3.1M 39.24M 3.18M 3.11M 136M |
| Net Debt | 525M 5.55M 4.78M 4.41M 4.14M 7.77M 7.85M 52.06M 20.28M 257M 20.83M 20.39M 891M | 374M 3.96M 3.41M 3.14M 2.95M 5.54M 5.6M 37.11M 14.46M 183M 14.85M 14.54M 635M |
Employees
499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-17 | 70.51 ₹ | +1.72% | 23,639 |
| 26-06-16 | 69.32 ₹ | -3.48% | 135,664 |
| 26-06-15 | 71.82 ₹ | +3.19% | 32,626 |
| 26-06-12 | 69.60 ₹ | +0.87% | 30,718 |
| 26-06-11 | 69.00 ₹ | -4.09% | 110,120 |
- Stock Market
- Stocks
- LYKALABS Stock
Select your edition
All financial news and data tailored to specific country editions
